Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Market Cap

Corcept Therapeutics has a market cap or net worth of $3.76 billion as of January 6, 2026. Its market cap has decreased by -34.85% in one year.

• Market Cap: 3.76B
• Enterprise Value: 3.25B
• 1-Year Change: -34.85%
• Ranking: #1580
• Category: Mid-Cap
• Stock Price: $35.78

Market Cap Chart

Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $3.76B, an increase of 1,229.91%. That is a compound annual growth rate of 12.64%.

Market Cap History

Date	Market Cap	% Change
Jan 5, 2026	3.68B	0.43%
Dec 31, 2025	3.66B	-30.67%
Dec 31, 2024	5.28B	57.69%
Dec 29, 2023	3.35B	53.13%
Dec 30, 2022	2.19B	-4.35%
Dec 31, 2021	2.29B	-24.78%
Dec 31, 2020	3.04B	119.78%
Dec 31, 2019	1.38B	-10.36%
Dec 31, 2018	1.54B	-25.15%
Dec 29, 2017	2.06B	155.69%
Dec 30, 2016	806.10M	48.81%
Dec 31, 2015	541.70M	78.43%
Dec 31, 2014	303.60M	-5.24%
Dec 31, 2013	320.40M	124.53%
Dec 31, 2012	142.70M	-50.47%
Dec 30, 2011	288.10M	3.11%
Dec 31, 2010	279.40M	60.85%
Dec 31, 2009	173.70M	248.10%
Dec 31, 2008	49.90M	-59.17%
Dec 31, 2007	122.20M	336.43%
Dec 29, 2006	28.00M	-66.22%
Dec 30, 2005	82.90M	-41.54%
Dec 31, 2004	141.80M	-49.89%
Apr 14, 2004	283.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	952.72B
Johnson & Johnson	493.40B
AbbVie	395.77B
UnitedHealth Group	316.11B
AstraZeneca	293.89B
Merck & Co.	270.22B
Novartis AG	268.87B
Novo Nordisk	253.02B